NO168173C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater

Info

Publication number
NO168173C
NO168173C NO862485A NO862485A NO168173C NO 168173 C NO168173 C NO 168173C NO 862485 A NO862485 A NO 862485A NO 862485 A NO862485 A NO 862485A NO 168173 C NO168173 C NO 168173C
Authority
NO
Norway
Prior art keywords
branched
straight
alkyl
imidazolidinacetamide
oxo
Prior art date
Application number
NO862485A
Other languages
English (en)
Norwegian (no)
Other versions
NO168173B (no
NO862485L (no
NO862485D0 (no
Inventor
Mario Pinza
Ugo Pfeiffer
Carlo Farina
Silvano Banfi
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of NO862485D0 publication Critical patent/NO862485D0/no
Publication of NO862485L publication Critical patent/NO862485L/no
Publication of NO168173B publication Critical patent/NO168173B/no
Publication of NO168173C publication Critical patent/NO168173C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO862485A 1985-06-21 1986-06-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater NO168173C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8521235A IT1209644B (it) 1985-06-21 1985-06-21 Composti farmacologicamente attivi.

Publications (4)

Publication Number Publication Date
NO862485D0 NO862485D0 (no) 1986-06-20
NO862485L NO862485L (no) 1986-12-22
NO168173B NO168173B (no) 1991-10-14
NO168173C true NO168173C (no) 1992-01-22

Family

ID=11178813

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862485A NO168173C (no) 1985-06-21 1986-06-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater

Country Status (19)

Country Link
US (1) US4719222A (da)
EP (1) EP0206729B1 (da)
JP (1) JPH0696558B2 (da)
KR (1) KR870000304A (da)
AT (1) ATE60787T1 (da)
AU (1) AU586259B2 (da)
CA (1) CA1271598A (da)
DE (1) DE3677418D1 (da)
DK (1) DK290486A (da)
ES (1) ES8800165A1 (da)
FI (1) FI862421A7 (da)
GR (1) GR861579B (da)
HU (1) HUT41740A (da)
IL (1) IL79137A (da)
IT (1) IT1209644B (da)
NO (1) NO168173C (da)
PH (1) PH22131A (da)
PT (1) PT82814B (da)
ZA (1) ZA864447B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1222367B (it) * 1985-06-21 1990-09-05 Isf Spa Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
FR2677984B1 (fr) * 1991-06-21 1994-02-25 Elf Sanofi Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
CA2225325A1 (en) * 1997-12-19 1999-06-19 The University Of British Columbia Hemiasterlin analogs
WO2008132139A2 (en) * 2007-04-27 2008-11-06 Ucb Pharma S.A. New heterocyclic derivatives useful for the treatment of cns disorders
CA2930804C (en) 2014-01-22 2023-03-21 Helen Of Troy Limited Mop with removable secondary cleaning head
EP4347573A1 (en) 2021-05-26 2024-04-10 The Procter & Gamble Company Pro-benefit-agent compounds with heterocyclic moieties
EP4450489A1 (en) * 2023-04-18 2024-10-23 Synaffix B.V. Stable 4-isoxazoline conjugates
WO2024218164A1 (en) * 2023-04-17 2024-10-24 Synaffix B.V. Stable 4-isoxazoline conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH470396A (de) * 1963-08-12 1969-03-31 Hoffmann La Roche Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
IT1222367B (it) * 1985-06-21 1990-09-05 Isf Spa Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici

Also Published As

Publication number Publication date
JPS6230762A (ja) 1987-02-09
ATE60787T1 (de) 1991-02-15
DE3677418D1 (de) 1991-03-14
ZA864447B (en) 1987-02-25
FI862421L (fi) 1986-12-22
NO168173B (no) 1991-10-14
PH22131A (en) 1988-06-01
AU5891886A (en) 1986-12-24
CA1271598A (en) 1990-07-10
IT8521235A0 (it) 1985-06-21
AU586259B2 (en) 1989-07-06
EP0206729A3 (en) 1989-01-11
NO862485L (no) 1986-12-22
GR861579B (en) 1986-10-21
KR870000304A (ko) 1987-02-17
PT82814B (pt) 1988-04-21
PT82814A (en) 1986-07-01
NO862485D0 (no) 1986-06-20
EP0206729B1 (en) 1991-02-06
DK290486A (da) 1987-02-23
ES8800165A1 (es) 1987-11-01
US4719222A (en) 1988-01-12
ES556352A0 (es) 1987-11-01
FI862421A7 (fi) 1986-12-22
HUT41740A (en) 1987-05-28
DK290486D0 (da) 1986-06-20
JPH0696558B2 (ja) 1994-11-30
FI862421A0 (fi) 1986-06-06
EP0206729A2 (en) 1986-12-30
IL79137A (en) 1991-07-18
IT1209644B (it) 1989-08-30

Similar Documents

Publication Publication Date Title
NO165799C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte 2-oksindol-1-karboksamider og mellomprodukter for anvendelse ved fremgansmaaten.
NO168173C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater
NO168428C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt pyrrolidonderivat
NO166409C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser.